RT Journal Article
SR Electronic
T1 Asynchronous influenza vaccination and adverse maternal-child health outcomes in the Brazilian semiarid, 2013 to 2018: the INFLUEN-SA Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.24.20180455
DO 10.1101/2020.08.24.20180455
A1 Q Filho, José
A1 Junior, Francisco S
A1 Lima, Thaisy BR
A1 AF Viana, Vânia
A1 Burgoa, Jaqueline SV
A1 Soares, Alberto M
A1 M Leite, Álvaro
A1 Herron, Simone A
A1 Newland, Hunter L
A1 Sarnaik, Kunaal S
A1 Hanson, Gabriel F
A1 Papin, Jason A
A1 Moore, Sean R
A1 Lima, Aldo AM
YR 2021
UL http://medrxiv.org/content/early/2021/06/15/2020.08.24.20180455.abstract
AB Recent models indicate seasonal influenza transmission in Brazil begins annually in the semiarid state of Ceará (pop. 8.8M)—before vaccine campaigns begin. To assess the extent and maternal-child health consequences of this misalignment, we tracked severe acute respiratory infections (SARI), influenza, and influenza immunizations from 2013-2018. Of 3,297 SARI cases, 145 (4%) occurred in pregnancy. Vaccine coverage was >80%; however, campaigns often occurred during or after peak influenza. Birth weights nadired and prematurity increased 30-40 weeks following peak influenza, by a magnitude of 40g and 10.7% to 15.5%, respectively. We identified 61 babies of mothers with gestational SARI; they weighed 10% less at birth (P = 0·019) and were more often premature (OR: 2.944; 95% CI: 1.100 – 7.879) relative to controls (n=122). Mistiming of influenza vaccination adversely impacts pregnancy and birth outcomes in Ceará, with critical implications for influenza transmission dynamics nationally.Competing Interest StatementThe authors have declared no competing interest.Funding StatementINFLUEN-SA Brazil was supported by Grand Challenge Explorations-Brazil, with funding from the Bill & Melinda Gates Foundation (Seattle, WA; ID OPP1202179), the Conselho Nacional de Desenvolvimento Científico e Tecnológico (Brasília, Brazil; 443771/2018-9) and the Fundação Cearense de Apoio a Pesquisa (Fortaleza, CE, Brazil; GCE-00147-00005.01.00/19). This study was also supported by CAPES-Print UFC internationalization (Programa CAPES/n° do AUXPE: 88887.311922/2018-00) and the NIH/Fogarty International Center (K02 TW008767).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We conducted this study with approval from the Ethical Review Committees of the Federal University of Ceará, Fortaleza, CE, Brazil (register) and the State Health Secretariat, Fortaleza, CE, Brazil (register at CGTES/NUVEN). This study used guaranteed public access information under the terms of Law # 12,527, of November 18, 2011, and used aggregated information from deidentified databases in a manner consistent with the provisions of resolution CNS # 510, April 7, 2016 (Official Gazette of the Union; Published on: 24/05/2016, Edition: 98, Section: 1, Page: 44, National Health Council, Ministry of Health, Brasília, Brazil).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, JFQ, upon reasonable request.